(Nasdaq: DFTX) (“Definium” or the “Company”), a late-stage clinical biopharmaceutical company developing a new generation of therapeutics intended to address the underlying causes of psychiatric and ...
FacebookLikeShareTweetEmail A damning new report has accused The Spectator magazine of waging a sustained campaign of ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果